Cargando…

Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity

Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, ‘an apple a day keeps the doctor away’. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability mak...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Yu, Chen, Jiang, Yi, Kang, Peng, Ling, Xie, Jie, Gou, Xun, Peng, Tong, Tang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714487/
https://www.ncbi.nlm.nih.gov/pubmed/33222603
http://dx.doi.org/10.1080/19490976.2020.1842990
_version_ 1783618758514835456
author Zhang, Xiao-Yu
Chen, Jiang
Yi, Kang
Peng, Ling
Xie, Jie
Gou, Xun
Peng, Tong
Tang, Lin
author_facet Zhang, Xiao-Yu
Chen, Jiang
Yi, Kang
Peng, Ling
Xie, Jie
Gou, Xun
Peng, Tong
Tang, Lin
author_sort Zhang, Xiao-Yu
collection PubMed
description Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, ‘an apple a day keeps the doctor away’. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms. This study aimed to investigate the ameliorating effect of PHZ on high-fat diet (HFD)-induced obesity via modulating the “gut microbiota-barrier axis”. Firstly, C57BL/6 J mice were fed a normal chow diet (NCD) or HFD coadministered with or without PHZ for 12 weeks. Our results showed that PHZ supplementation significantly reduced HFD-induced body weight gain (P < .001), alleviated metabolic disorders (MDs) like insulin resistance (P < .001) and elevation of serum lipopolysaccharides (LPS) (P < .001), attenuated HFD-induced gut microbiota alterations, enhanced short-chain fatty acids (SCFAs) production (P < .001), and inhibited fecal LPS production (P < .001). To investigate the role of the fecal microbiota in the observed beneficial effects, a fecal microbiota transplantation (FMT) experiment was performed by transplanting the feces of the four groups of mice (as donor mice) daily collected from the fourth week to a new batch of acclimatized HFD-fed mice. Our results confirmed that feeding the gut contents of the PHZ-modulated mice could attenuate HFD-induced MDs, accompanied by enhanced glucagon-like peptide 2 (GLP-2) secretion (P < .001) and restoration of HFD-induced damage in the gut epithelial barrier. This study has provided evidence that the “gut microbiota-barrier axis” was an alternative target for the anti-obesity effect of PHZ. This work has also provided an explanation for the high efficacy of PHZ despite the low bioavailability, and PHZ holds great potential to be developed as a functional food ingredient.
format Online
Article
Text
id pubmed-7714487
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-77144872020-12-08 Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity Zhang, Xiao-Yu Chen, Jiang Yi, Kang Peng, Ling Xie, Jie Gou, Xun Peng, Tong Tang, Lin Gut Microbes Research Paper Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, ‘an apple a day keeps the doctor away’. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms. This study aimed to investigate the ameliorating effect of PHZ on high-fat diet (HFD)-induced obesity via modulating the “gut microbiota-barrier axis”. Firstly, C57BL/6 J mice were fed a normal chow diet (NCD) or HFD coadministered with or without PHZ for 12 weeks. Our results showed that PHZ supplementation significantly reduced HFD-induced body weight gain (P < .001), alleviated metabolic disorders (MDs) like insulin resistance (P < .001) and elevation of serum lipopolysaccharides (LPS) (P < .001), attenuated HFD-induced gut microbiota alterations, enhanced short-chain fatty acids (SCFAs) production (P < .001), and inhibited fecal LPS production (P < .001). To investigate the role of the fecal microbiota in the observed beneficial effects, a fecal microbiota transplantation (FMT) experiment was performed by transplanting the feces of the four groups of mice (as donor mice) daily collected from the fourth week to a new batch of acclimatized HFD-fed mice. Our results confirmed that feeding the gut contents of the PHZ-modulated mice could attenuate HFD-induced MDs, accompanied by enhanced glucagon-like peptide 2 (GLP-2) secretion (P < .001) and restoration of HFD-induced damage in the gut epithelial barrier. This study has provided evidence that the “gut microbiota-barrier axis” was an alternative target for the anti-obesity effect of PHZ. This work has also provided an explanation for the high efficacy of PHZ despite the low bioavailability, and PHZ holds great potential to be developed as a functional food ingredient. Taylor & Francis 2020-11-23 /pmc/articles/PMC7714487/ /pubmed/33222603 http://dx.doi.org/10.1080/19490976.2020.1842990 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Zhang, Xiao-Yu
Chen, Jiang
Yi, Kang
Peng, Ling
Xie, Jie
Gou, Xun
Peng, Tong
Tang, Lin
Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title_full Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title_fullStr Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title_full_unstemmed Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title_short Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
title_sort phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714487/
https://www.ncbi.nlm.nih.gov/pubmed/33222603
http://dx.doi.org/10.1080/19490976.2020.1842990
work_keys_str_mv AT zhangxiaoyu phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT chenjiang phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT yikang phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT pengling phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT xiejie phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT gouxun phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT pengtong phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity
AT tanglin phlorizinamelioratesobesityassociatedendotoxemiaandinsulinresistanceinhighfatdietfedmicebytargetingthegutmicrobiotaandintestinalbarrierintegrity